Suppr超能文献

腹膜透析的充分性

Adequacy of peritoneal dialysis.

作者信息

Burkart J M

机构信息

Department of Internal Medicine/Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

出版信息

Adv Ren Replace Ther. 2000 Oct;7(4):310-23. doi: 10.1053/jarr.2000.18031.

Abstract

The National Kidney Foundation-Dialysis Outcomes Quality Initiatives guidelines have standardized many aspects of treating end-stage renal disease patients with peritoneal dialysis in an attempt to improve overall patient outcome. While recommending certain total solute clearance goals, the guidelines have also pointed out deficiencies in our knowledge base and precipitated many controversies. Some of these controversies have been resolved while others may have been interpreted wrongly, unnecessarily resulting in transfer of patients from peritoneal dialysis to hemodialysis due to "failure to meet adequacy targets" even when doing well clinically. This report reviews the rationale for the original guidelines and their subsequent modification. It also outlines a rational approach toward prescription modification based on peritoneal physiology. Specific solute clearance target goals discussed are the modifications for continuous ambulatory peritoneal dialysis (CAPD) and cycler peritoneal dialysis (CCPD), and a review of what solute clearance targets subsequent guidelines from other countries have used. Some examples are as follows: new guidelines suggest that solute clearance goals for creatine clearance should differ for low and low-average transporters than for high and high-average transporters (weekly clearance of 50 and 60 1/1.73 m(2), respectively) while Kt/V targets remain unchanged. Also discussed is the rationale for having the same target for patients on CCPD with a mid-day exchange as those for patients on CAPD. We are also reminded that solute clearance is only one aspect of "adequate" dialysis-blood pressure and volume control are equally important, and ways to maintain euvolemia and blood pressure control are discussed in the context of prescription management.

摘要

美国国家肾脏基金会透析预后质量倡议指南对终末期肾病患者进行腹膜透析治疗的诸多方面进行了标准化,以改善患者的总体预后。在推荐特定的总溶质清除目标时,该指南也指出了我们知识库中的不足之处,并引发了诸多争议。其中一些争议已得到解决,而另一些可能被错误解读,甚至导致一些临床状况良好的患者因“未达到充分性目标”而从腹膜透析转为血液透析。本报告回顾了原始指南的依据及其后续修订情况。它还概述了基于腹膜生理学的合理处方调整方法。所讨论的特定溶质清除目标包括持续性非卧床腹膜透析(CAPD)和循环式腹膜透析(CCPD)的调整,以及对其他国家后续指南所采用的溶质清除目标的综述。示例如下:新指南表明,低转运和低平均转运患者的肌酐清除溶质清除目标应不同于高转运和高平均转运患者(每周清除率分别为50和60 l/1.73 m²),而Kt/V目标保持不变。还讨论了CCPD患者中午交换与CAPD患者具有相同目标的依据。我们还需谨记,溶质清除只是“充分”透析的一个方面——血压和容量控制同样重要,并且在处方管理的背景下讨论了维持血容量正常和血压控制的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验